Home   Contact   Sitemap   中文   CAS
About Us
Research
Research Areas
Strategic Plans
News
People
Education & Training
Resources
Societies Publications
Int'l Cooperation
Papers
Join Us
Links
Location: Home > Research > Research Progress
TEXT SIZE: A A A PRINT CLOSE
Preclinical Study of Anti-tumor New Drug—Modified Staphylococcus aureus Enterotoxin C2 Protein Held

The project is charged by our institute . The seminar was held in our institute on June 26, 2014. Academician Changxiao Liu and Scientist Yongming Cai from Tianjin Phamaceutical Research Institute, Board Chairman Juyu Chen and executive manager Bing Hu of Shenyang Xiehe Biological Phamaceutical Cooperation Limited and Prof Chenggang Zhang and Prof Huiwen Zhang and other members in the research group of IAE presented. 

Prof Huiwen Zhang reported the periodic results, dressed the pressing tasks and the major difficulties ahead. Board Chairman Juyu Chen and executive manager Bing Hu of Shenyang Xiehe Biological Phamaceutical Cooperation Limited expressed fully support to the further research work of the project. Prof Chenggang Zhang clearly expressed the requests and constructive suggestions to the work for related institutions. 

Finaly, Academician Changxiao Liu summarized the meeting, requested that the research group should work according to the rules and standards of State Food and Drug Administration; The related organizations should actively communicate and cooperate each other in the work to solve problems appeared and fufill the task for the Twelfth Five Year Plan. 

After the meeting, the attended persons visited laborerory and workshop in Shenyang Xiehe Biological Phamaceutical Cooperation. 

 







Copyright©2002-2009 Institute of Applied Ecology.Chinese Academy of Sciences
Email: webmaster@iae.ac.cn